* If you want to update the article please login/register
However, IDDVT was estimated to account for about half of all DVT related to ultrasound in daily clinical practice, and optimal patient management techniques are becoming more applicable. The new American College of Chest Physicians guidelines recommend the same treatment for IDDVT patients with cancer as proximal DVT patients with cancer. We will randomly assign IDDVT patients with active cancer either edoxaban for 3 months or edoxaban for 12 months.
Source link: https://clinicaltrials.gov/ct2/show/NCT03895502
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions